RxDoctor Payments Data

Elizabeth di, MD

Family Medicine · Saint Augustine, FLNPI 1568824530

Payments from drug & device makers

$2,685in general payments, 2019–2025

Across 144 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$709
  • Amgen$445
  • Novo Nordisk$337
  • Pfizer$325
  • Lilly USA, LLC$320
  • AbbVie$199
  • plus $351 from 13 others

What the payments were for

  • Food & beverage$2,685100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,685 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$25,192
Medicare patients
68
Services billed
284

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide21$21,405
JardianceEmpagliflozin11$14,481
EliquisApixaban16$13,386
Levothyroxine Sodium33$544
Oxybutynin Chloride ErOxybutynin Chloride16$537
Atorvastatin Calcium43$513
Gabapentin27$440
Amlodipine Besylate68$356
Losartan Potassium34$306
Trazodone Hcl21$280
Metoprolol Succinate21$267
Omeprazole17$257
Lisinopril34$232
Tamsulosin Hcl14$218
Pantoprazole Sodium18$199

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$320$21,40521 claims
Boehringer IngelheimJardiance$92$14,48111 claims
PfizerEliquis$325$13,38616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Saint Augustine

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →